罗氏转染试剂说明书
1818
Gene Knockdown
A Versatile New Lipofection Reagent for Co-Transfection of DNA and siRNA X-tremeGENE siRNA Transfection Reagent Robert Slany Department of Genetics, Friedrich-Alexander University, Erlangen, Germany Coresponding author: rslany@biologie.uni-erlangen.de
Introduction Small inhibitory RNAs (siRNAs) have become the focus of interest in many laboratories. For the first time, these molecules offer an easy way to knock down the expression of selected genes in mammalian cells without having to resort to classical gene knockout techniques. The process of siRNA-mediated gene silencing is evolutionarily highly conserved. Probably all higher eukaryotes contain an enzymatic system (Dicer RNase) that is required to process double-stranded RNAs (dsRNA) to small“guidance” molecules. The resulting short 21- to 24-bp double-stranded RNA (siRNA) activates a cellular RNase system (RISC complex) that degrades any mRNA with complementary sequence to the siRNA. A breakthrough development for the application of RNA interference (RNAi) in mammalian cells was the discovery that direct introduction of short 21-bp dsRNA oligonucleotides into cells mediates effective gene silencing but does not trigger the so-called interferon response. This mechanism is present in mammalian cells as a defense against viruses and shuts down protein synthesis in reaction to the presence of any long dsRNA, irrespective of its sequence[1]. The practical application of RNAi in the laboratory therefore requires a method that allows the effective introduction of short dsRNA molecules into mammalian cells. An additional obstacle to overcome is the need for optimization of the siRNA sequence. Not every 21-bp dsRNA shows the same efficiency in silencing the corresponding mRNA. Despite the availability of sophisticated siRNA computer design tools, a certain amount of actual bench testing is still necessary. On many occasions, there is strong demand for a test system that is simple to manipulate and allows quick pre-testing of potential RNAi oligonucleotides for their knock-down efficiency towards the protein of interest. The simultaneous transfection of siRNA and an expression plasmid for the protein to be silenced offers a unique solution to this practical problem. An additional benefit of this system is that silencing can be detected at the protein level even if no antibody against
the target protein is available. A large variety of epitope tags can be fused to the cDNA corresponding to the target gene if it is expressed ectopically from a vector. Moreover, this approach also allows an assessment of the siRNA specificity, which needs to be checked in every RNAi experiment. Possible off-target effects can be revealed by including an expression vector for a target protein that carries a mutation in the siRNA recognition sequence. Since classical calcium phosphate transfection methods are very inefficient for the transfection of small dsRNA molecules, a series of newly deve
loped lipofection reagents were tested for their efficacy in delivering DNA as well as siRNA into cells.
Robert Slany
Materials and Methods One day prior to transfection, the human embryonic kidney cell line 293T was plated in 4 ml DMEM (4.5 g/l glucose, supplemented with 10% FCS and penicillin/streptomycin) into 6-well plates at a density of 1x 106 cells/ well. Following over-night incubation, the medium was changed to 2 ml of antibiotic-free DMEM/FCS. All siRNAs used were chemically synthesized by Dharmacon Inc. (Lafayette, CO, USA). For transfection with X-tremeGENE siRNA Transfection Reagent, 0.6µg expression vector (based on a CMV promoter) and 6.25µl of a 20-µM solution of either a specific siRNA duplex or a control siRNA directed against the nuclear protein Lamin C were diluted in 125µl serum-free DMEM (total nucleic acid content 2.5µg). In parallel, 25µl X-tremeGENE siRNA Transfection Reagent was added to 100µl serum-free DMEM, and the resulting mixture was combined immediately with the diluted nucleic acids. After 20 minutes incubation at room temperature the solution was added dropwise to the cells. Without any further medium change the cells were assessed for vitality by microscopic inspection 24 hours after lipofection and subsequently lysed for protein analysis by immunoblot according to standard methods. Control reactions
BIOCHEMICA· NO. 3· 2004

如何使用本产品 2.1 实验开始前 X-tremeGENE HP DNA Transfection Reagent 试剂用量 转染时单层细胞汇合度应在 70-90%,为进行反应条件优化,进行 X-tremeGENE HP...
x 1 ml 0.4 ml 1.0 ml 5 x 1 ml 1 ml 5 x 1 ml X-tremeGENE 9 DNA Transfection Reagent X-tremeGENE siRNA Transfection Reagent For life science ...
We have optimized the method for mediumscale functional studies with expression plasmids and siRNAs using X-tremeGENE siRNA Transfection Reagent [2]. Here we...
X-tremeGENE HP DNA Transfection Reagent ? 此外,X-tremeGENE siRNA Transfection Reagent 可帮助您有效转染 siRNA,或共 转 siRNA 和 DNA。 转染指南以下信息可...
X-tremeGENE HP DNA Transfection Reagent X-tremeGENE 9 DNA Transfection Reagent X-tremeGENE siRNA Transfection Reagent 转染 siRNA 或者共转染 siRNA 和质粒DNA ...
SUPPORT REAGENTS For optimal siRNA transfection efficiency, Santa Cruz Biotechnology’s siRNA Transfection Reagent: sc-29528 (0.3 ml), siRNA Transfection ...
SUPPORT REAGENTS For optimal siRNA transfection efficiency, Santa Cruz Biotechnology’s siRNA Transfection Reagent: sc-29528 (0.3 ml), siRNA Transfection ...
Choice of transfection reagent ? Transfection /DNA ratio ? The amount of ...X-tremeGENE siRNA转染试剂产品优势: Effective Gene Knockdown –––––– ...
Advanced transfection with Lipofectamine? 2000 reagent: primary neurons, siRNA, and high-throughput applications Methods, Volume 33, Issue 2, June 2004, ...
TurboFect in vitro transfection reagent_专业资料。TurboFect in vitro transfection reagentGeneral Considerations DNA Quality Requirements DNA quality is critical ...
热门文档